An Overview of the Drug Discovery Process - Webinar by GlobalCompliancePanel

Website http://bit.ly/1eRyiLg | Edit Freely

Category Webinar, Health, Medical, Pharma, Clinical

Deadline: February 06, 2014 | Date: February 06, 2014

Venue/Country: USA, U.S.A

Updated: 2014-01-23 13:35:43 (GMT+9)

Call For Papers - CFP

This webinar will provide an overview of the drug discovery process, the "R" in R&D of pharma organizations. It will describe the flow of activities from target identification through pre-clinical development. The key role of pharmacokinetics/pharmacodynamics will be explained.

This webinar will describe the types of decisions at each stage, and the types of data collected at each stage to enable those decisions. The roles of the various scientific components will explained: genomics, cell biology, biochemistry, pharmacology, pharmacokinetics. and chemistry. Throughout, it will define the various terms used - the 'lingo' of drug discovery research.

Why Should You Attend:

This webinar will be on interest to those who are moving into the drug discovery arena, or are planning to do that. For example, these may be technology companies or service providers. It will also be of interest to those already working in that arena, who want to have a broader perspective, e.g. clinicians, investors & financial analysts

Areas Covered in the Session:

Target identification and validation

Assay development

Lead discovery, including high-throughput screening

Lead optimization

pharmacokinetics/pharmacodynamics (PK/PD)

Animal safety studies and pre-clinical development

Who Will Benefit:

Research & development scientists

Clinical Monitors and Research Associates

Medical and Clinical Investigators and Study Coordinators

Statisticians & Data Management Professionals

CMC/Pharmaceutical Research Professionals

Regulatory Affairs Professionals

Project Managers

Senior Sales Managers

Analytical Development

Program Management

John has worked as a scientist and executive in pharmaceutical research for 25 years, at Pharmacia, Novartis, Vertex, and others. He has contributed to three marketed therapeutics. He is currently an independent consultant to the biotech/pharma sector. He is internationally recognized for his research in in silico drug discovery. He was trained as a theoretical chemist at Caltech and the Université Libre de Bruxelles.

Contact Information:

NetZealous LLC,

DBA GlobalCompliancePanel

161 Mission Falls Lane,

Suite 216, Fremont, CA 94539, USA

USA Phone:800-447-9407

Fax: 302-288-6884

webinarsglobalcompliancepanel.com

http://www.globalcompliancepanel.com

Event Link - http://bit.ly/1eRyiLg